Showing results (2901-2910 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|February 14, 2006
Recent progress in pharmacological and non-pharmacological treatment options of major depressionThomas C Baghai, Hans-Jürgen Möller, Rainer RupprechtCurrent Pharmaceutical Design|February 14, 2006
Potential disease targets for drugs that disrupt protein-- protein interactions of Grb2 and Crk family adaptorsStephan M Feller, Marc LewitzkyCurrent Pharmaceutical Design|February 14, 2006
Gene therapy for primary immunodeficiency diseases: recent progress and misgivingsTadashi ArigaCurrent Pharmaceutical Design|February 14, 2006
Calpain inhibition: a therapeutic strategy targeting multiple disease statesN O CarragherCurrent Pharmaceutical Design|February 14, 2006
Advances in chondroitin sulfate analysis: application in physiological and pathological States of connective tissue and during pharmacological treatment of osteoarthritisNicola VolpiCurrent Pharmaceutical Design|February 14, 2006
Reduction of Abeta levels in the Sprague Dawley rat after oral administration of the functional gamma-secretase inhibitor, DAPT: a novel non-transgenic model for Abeta production inhibitorsMohammed El Mouedden, Marc Vandermeeren, Theo Meert, et al.Current Pharmaceutical Design|February 14, 2006
Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neuronsMichael R D'Andrea, Robert G NageleCurrent Pharmaceutical Design|February 4, 2006
Complementary and alternative medical therapies in fibromyalgiaAysegul Jale Sarac, Ali GurCurrent Pharmaceutical Design|April 9, 2008
Sudden death and ventricular preexcitation: is it necessary to treat the asymptomatic patients?Carlo Pappone, Andrea Radinovic, Vincenzo SantinelliCurrent Pharmaceutical Design|April 9, 2008
Transcatheter ablation of supraventricular tachycardias in pediatric patientsAntonella De Santis, Giovanni Fazio, Massimo Stefano Silvetti, et al.Pageof 1,008